Does first-line treatment impact the cost-effectiveness of second-line treatment for elderly metastatic colon cancer patients?
C. Daniel Mullins
Consultant or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Novartis; Novo Nordisk; Pfizer
Honoraria - Celgene
Research Funding - Bayer; Pfizer
Andinet Woldemichael
No relevant relationships to disclose
Zhiyuan Zheng
No relevant relationships to disclose
Ebere Onukwugha
Consultant or Advisory Role - Janssen
Honoraria - IMH Health
Research Funding - Amgen; Bayer
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Nader Hanna
No relevant relationships to disclose